Brainstorm to announce first quarter 2023 financial results and provide a corporate update

New york , may 9, 2023 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference call to update shareholders on financial results for the first quarter ended march 31, 2023, and provide a corporate update, at 8:00 a.m. eastern time on monday, may 15th.
BCLI Ratings Summary
BCLI Quant Ranking